about
Effects of systemic immunosuppressive therapies for moderate-to-severe eczema in children and adultsMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysisRheumatologic manifestations of sarcoidosisCarvacrol and pomegranate extract in treating methotrexate-induced lung oxidative injury in rats1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis.Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.Increased sensitivity to apoptosis induced by methotrexate is mediated by JNK.Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models.Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.Short time administration of antirheumatic drugs - methotrexate as a strong inhibitor of osteoblast's proliferation in vitro.Certolizumab Pegol Efficacy Across Methotrexate Regimens: A Pre-Specified Analysis of Two Phase III Trials.Combination systemic therapies in psoriatic arthritis.Paracoccidioidomycosis induced by immunosuppressive drugs in a patient with rheumatoid arthritis and bone sarcoma: case report and review of the literature.Moving the injectable methotrexate service closer to home: a practice development initiative.Retrospective evaluation of continuation rates following a switch to subcutaneous methotrexate in rheumatoid arthritis patients failing to respond to or tolerate oral methotrexate: the MENTOR study.Methotrexate revisited: considerations for subcutaneous administration in RA.Management of Juvenile Idiopathic Arthritis: A Clinical Guide.Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.Effects of Pomegranate (Punica Granatum L.) Seed and Peel Methanolic Extracts on Oxidative Stress and Lipid Profile Changes Induced by Methotrexate in Rats.Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.Protective effects of carvacrol and pomegranate against methotrexate-induced intestinal damage in ratsIs there a place for nonbiological drugs in the treatment of rheumatoid arthritis?Current concepts in the genetic diagnostics of rheumatoid arthritis.The protective effect of intraperitoneal medical ozone preconditioning and treatment on hepatotoxicity induced by methotrexate.The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.Dry Olive Leaf Extract in Combination with Methotrexate Reduces Cell Damage in Early Rheumatoid Arthritis Patients-A Pilot Study.Medical ozone treatment ameliorates the acute distal colitis in rat.Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?
P2860
Q24188221-BE438328-42B0-453C-9576-3E684E322A84Q24202055-01088A9D-75EC-4B8F-A76A-D946EE9FD1C1Q24608644-86BFC864-B040-4669-BA43-DA8C20FC585AQ34413614-E960895B-DC04-4FCB-A806-574EC507ABC0Q34541409-AE8B5DCF-151F-4DDB-9451-A62700543A80Q35092982-9C0EFF9D-A6DF-4EFB-BA63-4EC14903EC38Q35190872-2B1481D5-A11D-4319-89A9-AC9ED5822BDBQ35415573-3DC1CBCB-C236-43A3-931B-EFE7BCAF16E9Q35645491-AA881E3C-A99C-4CD0-B799-F287CE78DFEBQ36453573-63865769-0107-4E7F-938B-F0EB1ACA0D3DQ37345837-D1DF2F27-B1BE-4A76-8FBD-BB2D49BEDA81Q37776265-02C5B1AF-E445-42D0-A6D4-B9D6BE24EB1AQ37848719-AE17BFA8-424A-4BB9-AA99-57D7E56F9F56Q38202606-19753D41-5858-47A9-B365-4CDF6D5DB19AQ38217687-37ECAF2E-AEBF-4F36-B6CA-CE8B584D50C8Q38272682-AA15EF60-8C9F-45AB-8E67-9F6C5D8F567EQ38916421-54A92C0B-7C15-4E45-8409-DB3F8B729D30Q38939820-EFAEDBD0-DEE7-4EAD-ACE9-ABE8EBCEC43FQ39461770-FB660D2F-BD28-436D-9C9B-0FFB2E725776Q41126517-FB29B524-6D07-4C82-AADA-2B7FF66D3A0EQ41714062-A7336A7B-EB65-4A4D-8A52-B43CB20123ACQ41863558-90E2A529-8B85-4FF6-9C3A-1B1C7CB846F7Q41948703-8769386F-9A5C-4368-8D49-296539701DB1Q42970803-947A743C-45C2-490C-A0AB-ADE061C90065Q43210002-BE8B5FE6-2E52-467F-B008-A3C736AD7187Q45349706-D409B9CB-C35B-419E-9772-23AD2D9701DAQ47632929-23C39136-D887-408C-811A-BFE61053C9BAQ50502906-1A1544A9-9A5B-4317-A9A1-72C443966F4DQ51716017-F43AA818-B435-43C6-8C9B-6D6519F3B2BBQ53101819-2C767580-934B-4F2B-AFA6-D7FCBF097E69Q53163901-94E7D824-ACEB-44F7-9FEC-DB0FF542D5F5Q53165185-6CF371B1-214D-4E2F-AC20-D6B2ADB08CE5Q55617607-700E3311-7A7C-42C0-9D24-6097D554BC21Q56768228-83EE8E56-C6E1-4290-BDA7-D16FE5F76BAA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An update on methotrexate.
@en
An update on methotrexate.
@nl
type
label
An update on methotrexate.
@en
An update on methotrexate.
@nl
prefLabel
An update on methotrexate.
@en
An update on methotrexate.
@nl
P1476
An update on methotrexate.
@en
P2093
Juergen Braun
P304
P356
10.1097/BOR.0B013E328329C79D
P577
2009-05-01T00:00:00Z